tert-Butyl 3,5-dimethylpiperazine-1-carboxylate

Catalog No. :
ACGANO314
CAS No. :
639068-43-2
Molecular Formula :
C11H22N2O2
Molecular Weight :
214.31

IUPAC Name:tert-butyl 3,5-dimethylpiperazine-1-carboxylate

tert-Butyl 3,5-dimethylpiperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$50.00Login to see priceIn stockIn stock
5g97%$157.00Login to see priceIn stockIn stock
25g97%$423.00Login to see priceIn stockIn stock
100g97%$1516.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3,5-dimethylpiperazine-1-carboxylate
IUPAC Nametert-butyl 3,5-dimethylpiperazine-1-carboxylate
MDL No.MFCD07371499
Molecular FormulaC11H22N2O2
Molecular Weight214.31
SMILESC(=O)(OC(C)(C)C)N1CC(NC(C1)C)C
InChI KeyNUZXPHIQZUYMOR-UHFFFAOYSA-N
Synonym3,5-Dimethyl-piperazine-1-carboxylic acid tert-butyl ester;Methisosildenafil-002;tert-Butyl 3,5-diMethylpiperazine-1-carboxylate;1-Piperazinecarboxylic acid, 3,5-diMethyl-, 1,1-diMethylethyl ester;2-Methyl-2-propanyl 3,5-dimethyl-1-piperazinecarboxylate;Methisosildenafil Impurity;Methisosildenafil Impurity 29;Methisosildenafil impure4
CAS No.639068-43-2

Synthetic Route by SureRoute

1. ACGANO314 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGANO314 route product structure diagram
    ACGANO314639068-43-2 In Stock
Inquiry

2. ACGANO314 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACGANO314 route product structure diagram
    ACGANO314639068-43-2 In Stock
Inquiry

Comments (0)